Pomegranate and cardiovascular diseases: Pomegranate juice polyphenolic antioxidants protect against oxidative stress and atherosclerosis development

Acta Horticulturae

Volumn 744, Issue , 2007, Pages 205-216

  Fuhrman, B ^a   Aviram, M ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Atherosclerosis; Atherosclerotic mice; LDL oxidation; Macrophages; Oxidative stress; Paraoxonase 1 (PON1); Pomegranate juice

Indexed keywords

LYTHRACEAE; MUS;

EID: 70449135028     PISSN: 05677572     EISSN: None     Source Type: Book Series    
DOI: 10.17660/ActaHortic.2007.744.21     Document Type: Conference Paper

References (39)

1. Aviram, M. 1999. Antioxidants in restenosis and atherosclerosis. Curr. Interven. Cardiol. Rep. 1: 66-78.
2. th Biennal Meeting of the Society for Free Radical Research International (Paris, France, July 16-20, 2002), by Monduzzi Editore S.p. A. - MEDIMOND Inc.
3. Aviram, M. and Dornfeld, L. 2001. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis, 158: 195-198.
4. Aviram, M. and Fuhrman, B. 1998. LDL oxidation by arterial wall macrophages depends on the antioxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants. Mol. Cell Biochem. 188: 149-159.
5. Aviram, M. and Fuhrman, B. 2003. Wine flavonoids, LDL cholesterol oxidation and atherosclerosis. pp. 140-159. In: Wine: a scientific exploration. M. Sandler and R. M. Pinder (eds.), Taylor and Francis, London, UK and NY, USA.
6. Aviram, M. and Rosenblat, M. 1994. Macrophage mediated oxidation of extracellular low density lipoprotein requires an initial binding of the lipoprotein to its receptor. J. Lipid Res. 35: 385-398.
7. Aviram, M. and Rosenblat, M. 2004. Oxidative stress in cardiovascular diseases: role of oxidized lipoproteins in macrophage foam cell formation and atherosclerosis. pp. 557-590. In: Redox Genome Interactions in Health and Disease. J. Fuchs, M. Podda and L. Packer (eds.), Marcel Dekker, NY.
8. Aviram, M. Vaya, J. and Fuhrman, B. 2004. Licorice root flavonoid antioxidants reduce LDL oxidation and attenuate cardiovascular diseases. Ch 27, pp. 595-614. In: Herbal Medicines: Molecular Basis of Biological Activity and Health. L. Packer, B. Halliwel and C. Nam Ong (eds.), Pub. Marcel Dekker, NY.
9. Aviram, M., Rosenblat, M., Etzioni, A. and Levy, R. 1996. Activation of NADPH oxidase is required for macrophage-mediated oxidation of low density lipoprotein. Metabolism 45: 1069-1079.
10. Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R., Bisgaier, C. L., Newton, R. S. and La Du, B. 1999. Human serum paraoxonase (PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 26: 892-904.
11. Aviram, M., Dornfeld, L., Rosenblat, M., Volkova, N., Kaplan, M., Hayek, T., Presser, D. and Fuhrman, B. 2000. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in the atherosclerotic apolipoprotein E-deficient mice. Am. J. Clin. Nutr. 71: 1062-1076.
12. Aviram, M., Dornfeld, L., Kent, U. and Hollenberg, P. 2001. Pomegranate juice consumption inhibits serum angiotensin II converting enzyme (ACE) activity: A possible role for cytochrome P-450 enzymes. Atherosclerosis 158: 195-198.
13. Aviram, M., Dornfeld, L., Kaplan, M., Coleman, R., Gaitini, D., Nitecki, S., Hofman, A., Rosenblat, M., Volkova, N., Presser, D., Attias, J., Hayek, T. and Fuhrman, B. 2002a. Pomegranate juice flavonoids inhibit low-density lipoprotein oxidation and cardiovascular diseases: studies in atherosclerotic mice and in humans. Drugs Ex. Clin. Res. 28: 49-62.
14. Aviram, M., Fuhrman, B., Rosenblat, M., Volkova, N., Kaplan, M., Hayek, T., Presser, D., Attias, J., Gaitini, D., Nitecki, S., Hoffman, A. and Dorenfeld, L. 2002b. Pomegranate juice polyphenols decreases oxidative stress, low-density lipoprotein atherogenic modifications and atherosclerosis. Free Radic. Res. 36 (Supplement 1) : 72-73.
15. Aviram, M., Rosenblat, M., Gaitini, D., Nitecki, S., Hoffman, A., Dornfeld, L., Volkova, N., Presser, D., Attias, J., Liker, H. and Hayek, T. 2004. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin. Nutr. 23: 423-433.
16. Aviram, M., Kaplan, M., Rosenblat, M. and Fuhrman, B. 2005. Dietary antioxidants against LDL oxidation and atherosclerosis development: protective role for paraoxonase.: p. 259-296. In: Handbook of Experimental Pharmacology (HEP) Vol. 170. Arteriosclerosis; Influence of Diet and Drugs. Ed. A. von Eckardstein.
17. Fuhrman, B. and Aviram, M. 2001a. Antiatherogenicity of nutritional antioxidants. Idrugs 4: 82-92.
18. Fuhrman, B. and Aviram, M. 2001b. Flavonoids protect LDL from oxidation and attenuate atherosclerosis. Curr. Opin. Lipidol. 12: 41-48.
19. nd Edition. E. Cadenas and L. Packer (eds.), Marcel Dekker, NY.
20. Fuhrman, B., Oiknine, J., Aviram, M. 1994. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL and affect their secretory properties. Atherosclerosis 111: 65-78.
21. Fuhrman, B., Oiknine, J., Keidar, S., Kaplan, M. and Aviram, M. 1997a. Increased uptake of low density lipoprotein (LDL) by oxidized macrophages is the result of enhanced LDL receptor activity and of progressive LDL oxidation. Free Radic. Biol. Med. 23: 34-46.
22. Fuhrman, B., Buch, S., Vaya, J., Belinky, P. A., Coleman, R., Hayek, T. and Aviram, M. 1997b. Licorice extract and its major polyphenol glabridin protect low density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E - deficient mice. Am. J. Clin. Nutr. 66: 267-275.
23. Fuhrman, B., Rosenblat, M., Hayek, T., Coleman, R. and Aviram, M. 2000. Ginger extract consumption reduces plasma cholesterol levels, inhibits LDL oxidation and attenuates development of atherosclerosis in the atherosclerotic apolipoprotein E-deficient mice. J. Nutr. 130: 1124-1131.
24. Fuhrman, B., Volkova, N., Coleman, R. and Aviram, M. 2005. Grape powder polyphenols attenuate atherosclerosis development in apolipoprotein E-deficient (E°) mice and reduce macrophage atherogenicity. J. Nutr. 135: 722-728.
25. Fuhrman, B., Volkova, N. and Aviram, M. 2005. Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J. Nutr. Biochem 16: 570-576.
26. Galley, H. F., Thornton, J., Howdle, P. D., Walker, B. E. and Webster, N. R. 1997. Combination oral antioxidant supplementation reduces blood pressure. Clin. Sci. 92: 361-365.
27. Glass, C. K. and Witztum, J. L. 2001. Atherosclerosis: The road ahead. Cell 104: 503-516.
28. Goldstein, J. L. and Brown, M. S. 1990. Regulation of the mevalonate pathway. Nature 343: 425-430.
29. Hayek, T., Fuhrman, B., Vaya, J., Rosenblat, M., Belinky, P., Coleman, R., Elis, A. and Aviram, M. 1997. Reduced progression of atherosclerosis in the apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin, or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17: 2744-2752.
30. Hertog, M. G., Kromhout, D., Aravanis, C., Blackburn, H., Buzina, R., Fidanza, F., Giampaoli, S., Jansen, A., Menotti, A. and Nedeljkovic, S. 1995. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 155: 381-386.
31. Kaplan, M. and Aviram, M. 1999. Oxidized low density lipoprotein: Atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase. Clin. Chem. Lab. Med. 37: 777-787.
32. Kaplan, M. and Aviram, M. 2004. Macrophage - mediated oxidation of LDL and atherogenesis: protective role for paraoxonases: Cellular Dysfunction in Atherosclerosis and Diabetes - Reports from Bench to Bedside. M. Simionesco, A. Sima and D. Popov (eds.), Romanian Academy Publishing House, Chapter 25, p. 336-351.
33. Kaplan, M., Hayek, T., Raz, A., Coleman, R., Dornfeld, L., Vaya, J. and Aviram, M. 2001. Pomegranate juice supplementation to atherosclerotic mice reduces macrophages lipid peroxidation, cellular cholesterol accumulation and development of atherosclerosis. J. Nutr. 131: 2082-2089.
34. Langley, P. 2000. Why a pomegranate? BMJ 321: 1153-1154.
35. Navab, M., Ananthramaiah, G. M., Reddy, S. T., Van Lenten, B. J., Ansell, B. J., Fonarow, G. C., Vahabzadeh, K., Hama, S., Hough, G., Kamranpour, N., Berliner, J. A., Lusis, A. J. and Fogelman, A. M. 2004. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J. Lipid Res. 45: 993-1007.
36. Rosenblat, M., Belinky, P., Vaya, J., Levy, R., Hayek, T., Coleman, R., Merchav, S. and Aviram, M. 1999. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell-mediated oxidation of low density lipoprotein: A possible role for protein kinase C. J. Biol. Chem. 274: 13790-13799.
37. Rosenblat, M., Volkova, N., Coleman, R. and Aviram, M. 2006a. Pomegranate byproduct administration to apolipoprotein E-deficient mice attenuates atherosclerosis development as a result of decreased macrophage oxidative stress and reduced cellular uptake of oxidized low density lipoprotein. J. Agric. Food Chem. 54: 1928-1935.
38. Rosenblat, M., Hayek, T. and Aviram, M. 2006b. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophage. Atherosclerosis (in press).
39. Van Acker, S. A. B. E., Van-den Berg, D. J., Tromp, M. N. J. L., Griffioen, D. H., van Bennekom, W. P., Van der Vijgh, W. J. F. and Bast, A. 1996. Structural aspects of antioxidants activity of flavonoids. Free Radic. Biol. Med. 20: 331-342.